Join to View Full Profile
675 N. St. Clair St., Galter 20-250Chicago, IL 60611
Phone+1 312-695-8146
Dr. Ross is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ross is a surgeon scientist who specializes in urology and urologic oncology and is a nationally recognized expert in prostate cancer. His research efforts focus on the development, testing and implementation of novel diagnostics and therapeutics with a goal of reducing the suffering from prostate cancer. Clinically, Dr. Ross performs prostate cancer screening, prostate biopsy (including MRI-fusion biopsy), active surveillance, robotic prostatectomy, open radical prostatectomy, and ablative therapies of the prostate. Prior to joining the Feinberg School of Medicine, Dr. Ross served as director of the Johns Hopkins Urology Prostate Cancer Program, the executive medical director of the Mary Crowley Cancer Research Center, and an associate chair of the US Oncology Genitourinary Research Committee.
Education & Training
Johns Hopkins UniversityResidency, Urology, 2006 - 2012- Johns Hopkins University School of MedicineClass of 2006
Certifications & Licensure
TX State Medical License 2017 - 2027
IL State Medical License 2020 - 2026
IN State Medical License 2024 - 2025
WI State Medical License 2024 - 2025
DC State Medical License 2024 - 2024
MD State Medical License 2010 - 2019
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
Clinical Trials
- rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance Start of enrollment: 2023 Jun 07
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Deciphering Resistance: Beyond the Androgen Paradigm; Report From the 2025 Coffey-Holden Prostate Cancer Academy Meeting.Tanya Stoyanova, Saul J Priceman, Ashley E Ross, Phuoc T Tran, Rana R McKay
The Prostate. 2026-03-01 - Factors Associated With Early Detection of Clinically Significant Prostate Cancer After a Negative Magnetic Resonance Imaging-Informed Biopsy.Jae Woong Jang, Nicole Handa, Ridwan Alam, Yutai Li, Sai Kumar
Urology Practice. 2026-03-01 - 1 citationsPerformance of the Prostate Health Index Test in Men With Prostate Specific Antigen Levels Between 10 and 20 ng/mL.Helen Holzbeierlein, Nalin Kundu, Nicole Handa, Jae Woong Jang, Eric V Li
Urology. 2026-02-01
Journal Articles
- Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate CancerEmmanuel S Antonarakis, Ashley E Ross, Michael A Gorin, Samuel R Denmeade, Channing J Paller, Kenneth J Pienta, Mario A Eisenberger, JAMA Oncology
Authored Content
- Clinical and Genomic Characterization of Low–Prostate-Specific Antigen, High-Grade Prostate CancerFebruary 2018
Press Mentions
14 Studies Presented at AUA 2024 Show Decipher Tests’ Ability to Help Personalize Care for Prostate and Bladder Cancer Patients and Advance Disease UnderstandingMay 6th, 2024- Beyond Genomics: AI Informing Decision Making in Prostate Cancer – Ashley RossJanuary 22nd, 2023
- PSMA PET Imaging in Clinical Practice - Thomas Hope & Jeremie CalaisJanuary 3rd, 2023
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/ashley-ross
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
